design, setting, and participants: a parallel-design study of 351 participants with hyperlipidemia from 4 participating academic centers across canada (quebec city, toronto, winnipeg, and vancouver) randomized between june 25, 2007, and february 19, 2009, to 1 of 3 treatments lasting 6 months.